Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

By Ming Li, Feng Gao, J. Mascola, L. Stamatatos, V. Polonis, M. Koutsoukos, G. Voss, P. Goepfert, Peter B. Gilbert, Kelli M. Greene and 7 more. Journal of Virology, 2005

1,147 citations recorded by the source corpus.

Subfields: Immunology, Infectious Diseases, Virology

View Paper: https://www.semanticscholar.org/paper/571e663644b80d093aaf9aed93dbea1f80809a4b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

1. Ian A. Wilson
2. Abdo A. Elfiky

In Virology

1. Beatrice H. Hahn
2. John C. Mingers
3. Leroy White

Citations in the corpus

• Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia (2008, background): “Neutralizing antibodies to the easily neutralized tier 1 (37) HIV-1 Env pseudoviruses such as B.”
• Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection (2008, background): “To the contrary, most viral env sequences coalesced to a MRCA near the time estimated for transmission based on Fiebig staging; coreceptor binding surfaces on transmitted/founder Envs (probed by 17b, 447-52D, and F425-B4e8) were conformationally masked; and transmitted/founder Envs were comparable t”
• Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies (2009, methodology): “ously (22) by using parental viruses obtained from the NIH ARRRP.”
• Crystal structure of a soluble cleaved HIV-1 envelope trimer (2013, methodology): “A single-cycle neutralization assay with TZM-bl target cells was performed as described previously (74).”